Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial
Morschhauser, Franck, Tilly, Hervé, Chaidos, Aristeidis, McKay, Pamela, Phillips, Tycel, Assouline, Sarit, Batlevi, Connie Lee, Campbell, Phillip, Ribrag, Vincent, Damaj, Gandhi Laurent, Dickinson, MJournal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(20)30441-1
Date:
October, 2020
Fichier:
PDF, 1015 KB
2020
File converter
Plus de résultats de recherche
More benefits 
